Debbie Cenziper on Muck Rack

Debbie Cenziper

Verified
Washington, D.C.
As seen in: ProPublica, CNN, MSN, El País, The Independent (UK), The Washington Post, TIME, Aol, Gizmodo, NDTV, SFGate and
Pulitzer Prize-winning investigative journalist, author and director of Medill Investigative Lab @NorthwesternU. Reporter @propublica.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Debbie

Contact Debbie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

What the FDA Won’t Tell You About Your Medications

|
By Jessica Lussenhop Verified, Debbie Cenziper Verified, Megan Rose Verified
| ProPublica
For years, the Food and Drug Administration told the public that generics are just as safe and effective as brand-name medications. But ProPublica reporters uncovered reports from the FDA’s own inspectors detailing everything from pigeons pooping onto boxes of sterilized equipment to evidence of a factory cheating on quality testing.
Open in Who Shared Issue with article?

The Clear Labels Act would change what you know about your prescription medication

|
By Debbie Cenziper Verified, Naisha Roy
| The Lund Report Verified
This story was originally published by ProPublica. Senators introduced legislation on Thursday that would require prescription drug labels to identify where the medication was made, adding momentum to a years-long campaign to bring more transparency to the often elusive generic drug industry.
Open in Who Shared Issue with article?

Clear Labels Act Would Require Manufacturing Locations on Prescription Drug Labels

|
By Debbie Cenziper Verified, Naisha Roy
| ProPublica
Senators introduced legislation on Thursday that would require prescription drug labels to identify where the medication was made, adding momentum to a yearslong campaign to bring more transparency to the often elusive generic drug industry. At a hearing last week, members of the Senate Special Committee on Aging criticized manufacturers for routinely concealing the locations of their drugmaking plants as well as the suppliers that provide key ingredients.
Open in Who Shared View Duplicates (4) Issue with article?
See all 342 licensed articles (367 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified